Pancreatic beta-cell function and islet-cell proliferation: effect of hyperinsulinaemia

Area of Science:

• Endocrinology
• Cell Biology
• Metabolic Research

Background:

• Pancreatic beta-cells are crucial for glucose homeostasis.
• Understanding beta-cell adaptation to altered insulin levels is vital for metabolic disease research.

Purpose of the Study:

• To investigate the effects of exogenous insulin on pancreatic beta-cell function and mass in rats.
• To determine the recovery dynamics of beta-cell function and proliferation after insulin suppression.

Main Methods:

• Rats received continuous subcutaneous insulin infusion to induce hyperinsulinemia and hypoglycemia.
• Pancreatic tissue, (pro)insulin mRNA levels, stored insulin, and islet cell proliferation (BrdU infusion) were quantified.
• Glucose levels, insulin release, and glucose tolerance were monitored during and after insulin treatment.

Main Results:

• Insulin treatment caused a 40% decline in endocrine tissue, 95% decrease in (pro)insulin mRNA, and 90% reduction in stored insulin.
• Islet cell proliferation decreased by 60% during insulin infusion.
• While glucose normalized within 2 days post-treatment, insulin stores, release, and glucose tolerance took ~1 week to recover. Islet cell proliferation showed a transient sixfold increase before returning to baseline.

Conclusions:

• Suppression of beta-cell function by exogenous insulin leads to significant, but reversible, loss of beta-cell mass and function.
• Recovery of insulin synthesis and release is a gradual process, not immediate.
• Transient hyperglycemia post-treatment may stimulate islet cell proliferation, suggesting a compensatory mechanism.